Search results
Results from the WOW.Com Content Network
The American Society of Hematology (ASH) is a professional organization representing hematologists, founded in 1958. Its annual meeting is held in December of every year and has attracted more than 30,000 attendees. [ 1 ]
Dunbar is currently the Secretary of the American Society of Hematology. She was the President of the American Society of Gene and Cell Therapy. [2] She was a faculty member for the ASH-European Hematology Association Translational Research Training in Hematology program from 2011 to 2016 and was co-director in 2016. [5]
Blood is a peer-reviewed medical journal published by the American Society of Hematology.It was established by William Dameshek in 1946. The journal changed from semimonthly (24 times annually) to weekly publication at the start of 2009.
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting -Preliminary data demonstrate that CTX112 ™ has the potential to provide meaningful clinical benefit with a well-tolerated safety profile using a standard lymphodepletion protocol-
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of Hematology (ASH) Annual Meeting and Exposition 2024 will feature a broad range of content covering OGM’s utility for research in areas including myeloid cancer, hematological malignancy, leukemia and blood disorders.
Multiple Myeloma (MM) At the ASH Annual Meeting, C4T presented safety and anti-myeloma data demonstrating cemsidomide has the potential to become a best-in-class IKZF1/3 degrader used as a backbone therapy of choice for patients with multiple myeloma where IKZF1/3 degradation is warranted. These data support the future development of ...
Dr. Dameshek served as president of the American Society of Hematology (ASH) in 1964. He made numerous contributions to ASH as well as the field of hematology and was the first editor of its journal Blood. Given Dr. Dameshek's accomplishments, ASH has named the Dameshek Prize in his honor.
The American Association for Cancer Research elected him a fellow of the AACR Academy in 2015. [4] In 2017, he served as the president [5] of the American Society of Hematology (ASH). He is a past recipient of ASH's William Dameshek Prize. [1] Anderson is the editor-in-chief of the journal Clinical Cancer Research. [6]